Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

Abroad (travel likely)RecruitingPHASE2

Conditions

Idiopathic Pulmonary Fibrosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Sec Clinical Research - East - Dothan - Graceland /ID# 278328, Dothan, Alabama, United States

  • Christie Clinic on University /ID# 277871, Champaign, Illinois, United States

  • Hannibal Regional Hospital /ID# 277984, Hannibal, Missouri, United States

  • Centre d'Investigation Clinique Mauricie /ID# 277949, Trois-Rivières, Quebec, Canada

  • Kaohsiung Medical University Chung-Ho Memorial Hospital /ID# 278029, Kaohsiung City, Taiwan

  • China Medical University Hospital /ID# 278039, Taichung, Taiwan

Study leads
  • ABBVIE INC.

    Study Director

    AbbVie